Press ReleasesApril 11, 20253 min read

A2 Milk Market expected to reach US$4,923.87 million by 2030

Key Highlights

A2 Milk Market Trends & Forecast: A2 Milk Market is projected to grow at a CAGR of 9.13% to reach a market size of US$4,923.87 million by 2030 from US$3,181.29 million...

A2 Milk Market Trends & Forecast:

A2 Milk Market is projected to grow at a CAGR of 9.13% to reach a market size of US$4,923.87 million by 2030 from US$3,181.29 million in 2025, according to a new report by Knowledge Sourcing Intelligence. The A2 milk market is driven by the health benefits offered by A2 milk, such as A2 beta-casein protein makes digestion easier, driving the demand among lactose-intolerant or dairy-sensitive customers. The growing demand for premium dairy products due to rising disposable income is propelling the market to grow. Further, the A2 beta-casein structure gives it a similarity to human breast milk, accelerating its demand in infant formulas. The market is experiencing product growing emphasis towards organic aligning itself with the growing sustainability trend among the eco-conscious and health-conscious customers. At the same time, companies are increasing the fortification of A2 milk with vitamins, minerals, and functional ingredients to target specific health needs, such as fortification of A2 milk with 120 IU vitamin D and 300 mg calcium/250 ml by Nestle in China.  However, the market is also facing limitations such as higher cost than the regular milk, limited supply of A2 cows and increasing competition from plant-based milk. The Asia Pacific region is anticipated to hold a significant amount of market share in the global A2 milk market. Countries like India, Australia & New Zealand, and China are making a favorable impact on market revenue. Growing demand from infant formulas, higher population, and rising disposable income is driving the market. ? View a sample of the report or purchase the complete study at: A2 Milk Market Report

A2 Milk Market Report Highlights:

  • The market is driven by growing demand from infant formula, health-conscious customers and increasing demand from lactose-intolerant customers.
  • The market is experiencing increasing fortification of A2 milk with minerals, vitamins and others.
  • There is a growing sustainability trend driving demand for organic A2 milk.
  • There is increasing product diversification by the companies to A2 yoghurts, cheeses and powders.
  • Asia-Pacific will continue to dominate the market and will be growing at the fastest rate due to the growing health-conscious market, while regions like Europe will experience growth in the premium segment.

A2 Milk Market Segmentation:

Knowledge Sourcing Intelligence has segmented the global A2 Milk Market based on Packaging, Application and Region: A2 Milk Market, By Packaging
  • Glass Bottles
  • Plastic Bottles and Pouches
  • Carton Packaging
  • Cans
A2 Milk Market, By Application
  • Infant Formula
  • Dairy Products
  • Bakery & Confectionery
  • Milk & Milk-Based Beverages
A2 Milk Market, By Region
  • North America
    • USA
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Others
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Others
  • Middle East and Africa (MEA)
    • South Arabia
    • UAE
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Thailand
    • Indonesia
    • Others

A2 Milk Market Key Players:

  • Fonterra Co-operative Group Limited
  • The A2 Milk Company Limited
  • Jersey Girl Organics
  • Oshun Food Products Private Limited
  • Organic Mandya
  • Country Delight
  • Provilac Dairy Farms Pvt. Ltd.
  • Gokripa Products
  • Krsnaa Farms
  • The Organic Carbon Pvt. Ltd.
  • GIRORGANIC
  • Amul (Gujarat Cooperative Milk Marketing Federation Ltd.)
  • ORIGIN
  • Vedaaz Organics Pvt. Ltd.
  • Sheldon Creek Dairy
Oat Milk Market Trends UHT Milk Market Share Milk Powder Market Size

Have questions?

More Press Releases

Aug 5, 2026

Lifestyle-Associated Cancer Epidemiology Market is expected to reach USD 13.12 billion by 2031

The worldwide market for lifestyle-associated cancer epidemiology is expected to expand rapidly, owing to the rising global awareness of modifiable risk factors such as tobacco use, obesity, poor diet, alcohol consumption, and physical inactivity, which together contribute significantly to cancer incidence. Health organizations, along with research institutions, are investing in enhanced surveillance, behavioral risk monitoring, cancer registries, and prevention strategies to address the growing burden of preventable cancers. In recent years, the World Health Organization and several national bodies have emphasized data-driven epidemiology. These initiatives support targeted interventions, policy measures, and screening programs. Additionally, the widespread adoption of digital epidemiology tools, precision prevention approaches, and AI-powered analytics is fueling the demand for robust epidemiology infrastructure worldwide.

Click here to read
Jul 30, 2026

Psycho-Oncology Digital Health Market is anticipated to surpass USD 290.01 million in 2031 at a CAGR of 8.5%

The psycho-oncology digital health market is expanding as healthcare providers increasingly integrate digital mental health solutions into cancer care. Growing demand for AI-driven platforms, digital cognitive behavioral therapy, telehealth, and mobile applications is improving access to psychological support. North America leads the market, while Asia Pacific is expected to witness the fastest growth.

Click here to read
Jul 24, 2026

Intratumoral Injection Therapy Market is expected to reach USD 630.39 million by 2031

The worldwide market for Intratumoral Injection Therapy is expected to experience substantial growth in the market due to the increasing demand for localized cancer treatments that are essential in enhancing therapeutic efficacy while also minimizing systemic toxicity. Intramural injection therapy is often involved with direct administration of therapeutic agents into tumors, which enables high local drug concentrations and targets immune activation. Growing interest in gene therapies, cancer immunotherapy, and on-politic viruses, including cytokine-based therapies are also accelerating market expansion.

Click here to read